Assessment of cervical cancer radioresponse by serum squamous cell carcinoma antigen and magnetic resonance imaging

Obstetrics and Gynecology

Volumn 100, Issue 4, 2002, Pages 781-787

  Ohara, Kiyoshi ^a   Tanaka, Yumiko Oishi ^a   Tsunoda, Hajime ^a   Nishida, Masato ^a   Sugahara, Shinji ^a   Itai, Yuji ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN;

ANTIGEN DETECTION; ARTICLE; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RADIATION RESPONSE; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE; UTERINE CERVIX CANCER;

ANTIGENS, NEOPLASM; CARCINOMA, SQUAMOUS CELL; CERVIX UTERI; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; RADIOTHERAPY, HIGH-ENERGY; REGRESSION ANALYSIS; SERPINS; TUMOR MARKERS, BIOLOGICAL; UTERINE CERVICAL NEOPLASMS;

EID: 0036806205     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0029-7844(02)02204-4     Document Type: Article

References (14)

1. Miller A.B., Hogestraeten B., Staquet M., Winker A. Reporting results of cancer treatment. Cancer. 47:1981;207-214.
2. Therasse P., Arbuck S.G., Eisenhouer E.A., Wanders J., Kaplan R.S., Rubinstein L., et al. New guidelines to evaluate the response to treatment in solid tumors. J Natl Cancer Inst. 92:2000;205-216.
3. Landmann C., Hunig R. Prostatic specific antigen as an indicator of response to radiotherapy in prostate cancer. Int J Radiat Oncol Biol Phys. 17:1989;1073-1076.
4. Kato H., Torigoe T. Radioimmunoassay for tumor antigen of human cervical squamous cell carcinoma. Cancer. 41:1977;1621-1628.
5. Bolli J.A.N., Doering D.L., Bosscher J.R., Day T.G. Jr, Rao C.V., Owens K., et al. Squamous cell carcinoma antigen Clinical utility in squamous cell carcinoma of the uterine cervix . Gynecol Oncol. 55:1994;169-173.
6. Togashi K., Morikawa K., Kataoka M.L., Konishi J. Cervical cancer. J Magn Reson Imaging. 8:1998;391-397.
7. Avall-Lundqvist E.H., Sjövall K., Nilsson B.R., Enoroth P.H.E. Prognostic significance of pretreatment serum levels of squamous cell carcinoma antigen and CA 125 in cervical carcinoma. Eur J Cancer. 28A:1992;1695-1702.
8. Duk J.M., Groenier K.H., de Bruijin H.W.A., Hollema H., ten Hoor K.A., van der Zee A.G.J., et al. Pretreatment serum squamous cell carcinoma antigen A newly identified prognostic factor in early-stage cervical carcinoma . J Clin Oncol. 14:1996;111-118.
9. Hong J.H., Tsai C.S., Chang J.T., Wang C.C., Lai C.H., Lee S.P., et al. The prognostic significance of pre- and posttreatment SCC levels in patients with squamous cell carcinoma of the cervix treated by radiotherapy. Int J Radiat Oncol Biol Phys. 41:1998;823-830.
10. Maruo T., Shibata K., Kimura A., Hoshina M., Mochizuki M. Tumor-associated antigen, TA-4, in the monitoring of the effects of therapy for squamous cell carcinoma of the uterine cervix Serial determination and tissue localization . Cancer. 56:1985;302-308.
11. Rose P.G., Baker S., Founier L., Nelson B.E., Hunter R.E. Serum squamous cell carcinoma antigen levels in invasive cervical cancer Prediction of response and recurrence . Am J Obstet Gynecol. 168:1993;942-946.
12. Ngan H.Y.S., Chan S.Y.W., Wong L.C., Choy D.T.K., Ma H.K. Serum squamous cell carcinoma antigen in the monitoring of radiotherapy treatment response in carcinoma of the cervix. Gynecol Oncol. 37:1990;260-263.
13. Flueckiger F., Ebner F., Poschauko H., Tamussino K., Einspieler R., Ranner G. Cervical cancer: Serial MR imaging before and after primary radiation A 2-year follow-up study . Radiology. 184:1992;89-93.
14. Hatano K, Sekiya Y., Araki H., Sakai M., Togawa T., Narita Y., et al. Evaluation of the therapeutic effect of radiotherapy on cervical cancer using magnetic resonance imaging. Int J Radiat Oncol Biol Phys. 45:1999;639-644.